focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BRJ China Credit Fund Exit

29 Apr 2014 07:00

RNS Number : 6858F
Adamas Finance Asia Limited
29 April 2014
 



Adamas Finance Asia Limited

 

 

BRJ China Credit Fund Fully Exited on Project Changlelu

 

BRJ China Credit Fund Limited ("BRJ" or the "Fund"), an investment fund into which Adamas Finance Asia Limited ("AFA" or the "Company" - AIM ticker: ADAM) invested US$500,000 earlier this month, has achieved a gross IRR of 31.83% from a newly-exited project, Project Changlelu.

BRJ was launched in August 2013 by Hong Kong-based Adamas Asset Management (HK) Limited ("Adamas"), which since February 2014 has been has been acting as AFA's investment manager.

Project Changlelu has now repaid in full both the principal and interest on a RMB15 million (approx. US$2.4 million) loan structured by Adamas, which was an early investment by the BRJ Fund. The loan, arranged as bridging finance for a successful leisure business in China, was deployed on 23 January 2014 and fully repaid on 23 April 2014. Because of the structure of the Fund, the exit has increased its Net Asset Value, and the cash generated becomes available for future investment.

The BRJ investment in Project Changlelu was in line the strategic approach followed by the Adamas investment team, which places strong emphasis on rigorous due diligence, tight management involvement and an insistence on robust collateral. The collateral backing Project Changlelu was a historic building located at Changlelu, Shanghai, with an overall loan-to-value ratio of approximately 57%. The collateral was further underpinned by corporate guarantors involved with the borrower.

AFA Chairman John Croft said: "We are delighted by this news, not least because it follows our announcement at the start of this month that the Company received a distribution of US$75,300 from a separate, September 2013, investment of US$1 million into another fund managed by Adamas - the Greater China Credit Fund. The BRJ exit from the Project Changlelu provides a further clear example of how we are already benefitting from the investment advice provided by the Adamas team in Asia."

BRJ was launched in August 2013 to provide capital for operationally-sound Chinese SMEs in need of short-term bridging finance not easily available within the PRC, where more than 90% of such companies have difficulty in obtaining bank funding. The Fund plans to invest US$50 million, seeking target returns of 24%-30% per annum with the objective of an annual dividend of 8%, payable semi-annually. It aims predominantly to use property as collateral on short-term structured loans.

Enquiries:

Adamas Finance Asia Limited

John Croft

+44 (0) 1825 830587

Nominated Adviser

W H Ireland Limited

Tim Feather

+44 (0) 113 394 6611

Broker

Laurel Capital Kingsway LLP

Suni Goonetillake

+44 (0) 203 330 0928

Public Relations Advisers

First City Public Relations (Hong Kong)

Allan Piper

+852 2854 2666

Tavistock Communications (London)

Simon Hudson

+44 (0) 207 920 3170

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZVLFLZZFLBBK
Date   Source Headline
24th Oct 201810:24 amRNSNet Asset Value Update
16th Oct 201810:34 amRNSDirector/PDMR Shareholding
13th Sep 20187:00 amRNSInterim Results for Six Months Ended 30 June 2018
17th Aug 201811:43 amRNSResult of AGM
13th Aug 201810:50 amRNSNet Asset Value Update
26th Jul 201812:06 pmRNSNet Asset Value Update
23rd Jul 20189:44 amRNSDisposal of Interest in Global Pharm
11th Jul 201810:38 amRNSResult of General Meeting
28th Jun 20183:50 pmRNSPosting of Annual Report and Accounts
21st Jun 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
21st Jun 20187:00 amRNSAppointment of Broker
15th Jun 20188:36 amRNSDisposal of Interest in Global Pharm & GM Notice
27th Apr 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Apr 20181:57 pmRNSResult of General Meeting
20th Apr 20188:49 amRNSDirector/PDMR Shareholding
5th Apr 20183:54 pmRNSDisposal and Notice of General Meeting
29th Mar 20187:00 amRNSUpdate on Disposal of Interest in Global Pharm
26th Mar 20184:44 pmRNSIncreased Ownership in HKMH
19th Mar 20187:00 amRNSNew Investment
8th Feb 201812:17 pmRNSUpdate - Net Asset Value
2nd Feb 20188:24 amRNSDirector/PDMR Shareholding
15th Jan 20187:00 amRNSFurther re. Disposal of Interest in Global Pharm
21st Dec 20178:54 amRNSIncrease in Shareholding in Hong Kong Mining
31st Oct 201710:23 amRNSNet Asset Value Update
2nd Oct 20177:00 amRNSAppointment of Director
22nd Sep 20177:00 amRNSInterim Results For Six Months End 30 June 2017
20th Sep 201711:18 amRNSAGM and Share Consolidation
15th Sep 20177:00 amRNSDisposal of Interest in Global Pharm
30th Aug 20174:50 pmRNSProposed Share Consolidation
4th Aug 20173:36 pmRNSUpdate on Global Pharm Convertible Bond
27th Jul 20177:00 amRNSNet Asset Value(s)
20th Jul 20179:43 amRNSDirectorate Change
20th Jul 20179:27 amRNSAnnual General Meeting
3rd Jul 20179:14 amRNSAppointment of Director
29th Jun 201710:45 amRNSFinal Results
22nd Jun 20178:46 amRNSFurther Payment of Proceeds for TTS Disposal
15th Jun 20179:43 amRNSPayment of Proceeds for TTS Project Disposal
25th May 201711:06 amRNSResult of Meeting
2nd May 20177:00 amRNSChange of Investment Manager and Investing Policy
24th Feb 201711:45 amRNSUPDATE ON TTS PROJECT DISPOSAL
8th Feb 20179:26 amRNSUPDATE ON TTS PROJECT DISPOSAL
31st Jan 20177:00 amRNSDistribution from GCCF
23rd Jan 20179:15 amRNSUPDATE: REDEMPTION OF GLOBAL PHARM CONVERTIBLE
13th Jan 20178:15 amRNSUPDATE ON TTS PROJECT DISPOSAL
4th Jan 20179:00 amRNSProposed Disposal
29th Dec 20167:00 amRNSDirector/PDMR Shareholding
22nd Dec 20161:18 pmRNSDirector/PDMR Shareholding
20th Dec 20164:19 pmRNSDirector/PDMR Shareholding
13th Dec 20169:23 amRNSDirector/PDMR Shareholding
6th Dec 201612:34 pmRNSCorrection to Director/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.